Literature DB >> 25328803

ALDH Activity Correlates with Metastatic Potential in Primary Sarcomas of Bone.

Nicholas Greco1, Trevor Schott1, Xiaodong Mu1, Adam Rothenberg1, Clifford Voigt1, Richard L McGough2, Mark Goodman2, Johnny Huard3, Kurt R Weiss3.   

Abstract

Osteosarcoma (OS), chondrosarcoma (CSA), and Ewings sarcoma (ES) are the most common primary malignancies of bone, and are rare diseases. As with all sarcomas, the prognosis of these diseases ultimately depends on the presence of metastatic disease. Survival is therefore closely linked with the biology and metastatic potential of a particular bone tumor's cells. Here we describe a significant correlation of aldehyde dehydrogenase (ALDH) activity and the presence/absence of distant metastases in ten consecutive cases of human bone sarcomas. Additionally, cultured human CSA cells, which are historically chemo- and radio-resistant, may be sensitive to the ALDH inhibitor, disulfiram. While it is premature to draw broad conclusions from such a small series, the importance of ALDH activity and inhibition in the metastatic potential of primary bone sarcomas should be investigated further.

Entities:  

Keywords:  Aldehyde Dehydrogenase; Chondrosarcoma; Ewings Sarcoma; Metastases; Osteosarcoma

Year:  2014        PMID: 25328803      PMCID: PMC4200537          DOI: 10.4236/jct.2014.54040

Source DB:  PubMed          Journal:  J Cancer Ther        ISSN: 2151-1934


  29 in total

Review 1.  Diagnosis and management of soft tissue sarcoma.

Authors:  Shiba Sinha; A Howard S Peach
Journal:  BMJ       Date:  2010-12-29

Review 2.  Dedifferentiated chondrosarcoma revisited.

Authors:  Andreas F Mavrogenis; Pietro Ruggieri; Mario Mercuri; Panayiotis J Papagelopoulos
Journal:  J Surg Orthop Adv       Date:  2011

Review 3.  Clinical trial end points for assessing efficacy of novel therapies for soft-tissue sarcomas.

Authors:  Bartosz Chmielowski; Noah Federman; William D Tap
Journal:  Expert Rev Anticancer Ther       Date:  2012-09       Impact factor: 4.512

4.  Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers.

Authors:  Shan Deng; Xiaojun Yang; Heini Lassus; Shun Liang; Sippy Kaur; Qunrui Ye; Chunsheng Li; Li-Ping Wang; Katherine F Roby; Sandra Orsulic; Denise C Connolly; Youcheng Zhang; Kathleen Montone; Ralf Bützow; George Coukos; Lin Zhang
Journal:  PLoS One       Date:  2010-04-21       Impact factor: 3.240

Review 5.  Proteomic approach toward personalized sarcoma treatment: lessons from prognostic biomarker discovery in gastrointestinal stromal tumor.

Authors:  Tadashi Kondo; Yoshiyuki Suehara; Kazutaka Kikuta; Daisuke Kubota; Takashi Tajima; Kenta Mukaihara; Hiroshi Ichikawa; Akira Kawai
Journal:  Proteomics Clin Appl       Date:  2013-01       Impact factor: 3.494

6.  Chick embryo extract demethylates tumor suppressor genes in osteosarcoma cells.

Authors:  Xiaodong Mu; Bolat Sultankulov; Riddhima Agarwal; Adel Mahjoub; Trevor Schott; Nicholas Greco; Johnny Huard; Kurt Weiss
Journal:  Clin Orthop Relat Res       Date:  2014-03       Impact factor: 4.176

7.  Osteosarcoma, chondrosarcoma, and Ewing's sarcoma: National Cancer Data Base Report.

Authors:  Timothy A Damron; William G Ward; Andrew Stewart
Journal:  Clin Orthop Relat Res       Date:  2007-06       Impact factor: 4.176

Review 8.  Metastatic carcinoma of the long bones.

Authors:  Anthony I Riccio; Felasfa M Wodajo; Martin Malawer
Journal:  Am Fam Physician       Date:  2007-11-15       Impact factor: 3.292

Review 9.  Review of therapeutic strategies for osteosarcoma, chondrosarcoma, and Ewing's sarcoma.

Authors:  Xing Dai; Wei Ma; Xijing He; Rajiv Kumar Jha
Journal:  Med Sci Monit       Date:  2011-08

10.  Rapamycin Inhibits ALDH Activity, Resistance to Oxidative Stress, and Metastatic Potential in Murine Osteosarcoma Cells.

Authors:  Xiaodong Mu; Christian Isaac; Trevor Schott; Johnny Huard; Kurt Weiss
Journal:  Sarcoma       Date:  2013-02-14
View more
  18 in total

1.  Aldehyde dehydrogenase isoform 1 (ALDH1) expression as a predictor of radiosensitivity in laryngeal cancer.

Authors:  M Martín; A Hinojar; L Cerezo; J García; M Lopez; J Prada; A Marín; C Gamallo
Journal:  Clin Transl Oncol       Date:  2015-11-16       Impact factor: 3.405

Review 2.  Update on Osteosarcoma.

Authors:  Rebekah Belayneh; Mitchell S Fourman; Sumail Bhogal; Kurt R Weiss
Journal:  Curr Oncol Rep       Date:  2021-04-21       Impact factor: 5.075

3.  The HDAC inhibitor Vorinostat diminishes the in vitro metastatic behavior of Osteosarcoma cells.

Authors:  Xiaodong Mu; Daniel Brynien; Kurt R Weiss
Journal:  Biomed Res Int       Date:  2015-02-17       Impact factor: 3.411

4.  Pediatric sarcomas.

Authors:  Junhua Cao; Qi An; Lei Wang
Journal:  Oncol Lett       Date:  2017-11-21       Impact factor: 2.967

5.  Do Patient-derived Spheroid Culture Models Have Relevance in Chondrosarcoma Research?

Authors:  Ruichen Ma; Jonathan Mandell; Feiqi Lu; Tanya Heim; Karen Schoedel; Anette Duensing; Rebecca J Watters; Kurt R Weiss
Journal:  Clin Orthop Relat Res       Date:  2021-03-01       Impact factor: 4.755

Review 6.  Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors.

Authors:  Mauricio Rodriguez-Torres; Alison L Allan
Journal:  Clin Exp Metastasis       Date:  2015-10-07       Impact factor: 5.150

7.  Retinal Targets ALDH Positive Cancer Stem Cell and Alters the Phenotype of Highly Metastatic Osteosarcoma Cells.

Authors:  Xiaodong Mu; Stuti Patel; Damel Mektepbayeva; Adel Mahjoub; Johnny Huard; Kurt Weiss
Journal:  Sarcoma       Date:  2015-12-24

8.  Aldh1 Expression and Activity Increase During Tumor Evolution in Sarcoma Cancer Stem Cell Populations.

Authors:  Lucia Martinez-Cruzado; Juan Tornin; Laura Santos; Aida Rodriguez; Javier García-Castro; Francisco Morís; Rene Rodriguez
Journal:  Sci Rep       Date:  2016-06-13       Impact factor: 4.379

Review 9.  The Challenges of Detecting Circulating Tumor Cells in Sarcoma.

Authors:  Marta Tellez-Gabriel; Hannah K Brown; Robin Young; Marie-Françoise Heymann; Dominique Heymann
Journal:  Front Oncol       Date:  2016-09-07       Impact factor: 6.244

Review 10.  Novel molecular insights and new therapeutic strategies in osteosarcoma.

Authors:  Babak Otoukesh; Bahram Boddouhi; Mehdi Moghtadaei; Peyman Kaghazian; Maria Kaghazian
Journal:  Cancer Cell Int       Date:  2018-10-16       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.